Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 15

Results For "US"

10146 News Found

India Pharma 2026 showcases sectoral transformation through four key plenary discussions
Policy | April 14, 2026

India Pharma 2026 showcases sectoral transformation through four key plenary discussions

Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals


India must build its own agile biopharma innovation model: ICMR DG Dr Rajiv Bahl
Policy | April 14, 2026

India must build its own agile biopharma innovation model: ICMR DG Dr Rajiv Bahl

At India Pharma 2026, Dr Bahl calls for experimentation over imitation as funding rises and translational ecosystem reforms gather pace


Unichem’s US arm recalls Buspirone tablets after stability test OOS result
News | April 13, 2026

Unichem’s US arm recalls Buspirone tablets after stability test OOS result

No adverse events reported; recall involves 5 mg 500-count bottles in the US market


India Pharma 2026 underscores policy momentum, innovation push, and self-reliance roadmap
Biopharma | April 13, 2026

India Pharma 2026 underscores policy momentum, innovation push, and self-reliance roadmap

The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness


Orbis India Partners Meet 2026 focuses on sustainable, climate-resilient eye care
Hospitals | April 13, 2026

Orbis India Partners Meet 2026 focuses on sustainable, climate-resilient eye care

Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems


C4 Therapeutics and Roche launch bold push into next-generation cancer drug modality
News | April 12, 2026

C4 Therapeutics and Roche launch bold push into next-generation cancer drug modality

The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation


Novartis expands global push to close life-saving gaps in heart disease & cancer care by 2030
News | April 12, 2026

Novartis expands global push to close life-saving gaps in heart disease & cancer care by 2030

Each program will rely on partnerships between Novartis teams and local networks—including health authorities, community organizations and private sector groups


Orbicular, Apotex win tentative USFDA nod for generic Ozempic
Drug Approval | April 11, 2026

Orbicular, Apotex win tentative USFDA nod for generic Ozempic

Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection


Zydus improves ESG rating to 68, up from 66 last year
News | April 11, 2026

Zydus improves ESG rating to 68, up from 66 last year

The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker


VDYNE gets FDA nod to launch pivotal US trial for tricuspid valve device
Medical Device | April 10, 2026

VDYNE gets FDA nod to launch pivotal US trial for tricuspid valve device

The approval clears the way for a US study at leading clinical centers to evaluate the safety and effectiveness of VDYNE’s system in patients